The RCF further diversifies Sirius’ debt, adding BNP Paribas as lenders for the first time, as well as ABN AMRO for the first time in over a decade, with HSBC completing the consortium. Panmure ...

After an unexpected exit as Salesforce co-CEO in 2022, Bret Taylor sat down with a friend, Benchmark’s Peter Fenton, to ...

In a tangible sign of Europe’s efforts to rebuild production capabilities that have long been dormant, Denmark asked ...

Other European startups are continuing to pursue eVTOLs, such as Ascendance and VoltAero in France, Sirius Aviation in ...

COLONIE — The Center for Economic Growth has created a new venture capital program that will provide promising startups in the Capital Region with a one-stop shop to obtain the venture capital ...

Sirius also holds a 35% stake in Titanium, its €350+ million German-focused joint venture with clients of AXA IM Alts. The Company's strategy centres on acquiring business parks at attractive yields ...

In that role, he led the sourcing and execution of strategic partnerships, acquisitions, and venture investments across Chubb’s Non-Life and Life businesses in North America, Europe, Asia Pacific, and ...

SAN DIEGO & SHANGHAI, May 09, 2025--Sirius Therapeutics today announced that it has successfully completed nearly $50 million Series B2 financing to advance clinical development of the Company’s ...

Sirius Therapeutics today announced that it has successfully completed nearly $50 million Series B2 financing ... A renowned corporate venture capital firm led the financing round that was ...

A renowned corporate venture capital firm led the financing round that was joined by a new investor, BioTrack Capital, and existing investors OrbiMed, Creacion Ventures, and Hankang Capital. “The ...

9. (tied) Sirius Therapeutics, $50M, biotech: San Diego-based Sirius Therapeutics, a biotech developing siRNA therapeutics for cardiometabolic disorders, raised a $50 million Series B2 financing led ...